Pneumocystis jirovecii Pneumonia and Use of mTOR Inhibitors in Kidney Transplantation

Clin Infect Dis. 2021 Aug 16;73(4):752-753. doi: 10.1093/cid/ciab020.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Kidney Transplantation* / adverse effects
  • Pneumocystis carinii*
  • Pneumonia, Pneumocystis* / drug therapy
  • Risk Factors
  • TOR Serine-Threonine Kinases

Substances

  • MTOR protein, human
  • TOR Serine-Threonine Kinases